Journal of Biological Chemistry · 2003 · 132 citations · 23 references
Life SciencesCell BiologyMolecular BiologyCell SignalingMolecular Cell BiologySignal TransductionCell Surface Receptor SignalingCell-surface ReceptorsGrowth Factor SignalingProtein Kinase CascadesReceptor RegulationReceptor Tyrosine Kinase SignalingFibroblast Growth Factor Receptor SignalingGrowth Factor Receptor ActivationProtein Tyrosine PhosphorylationRas-mitogen-activated Protein Kinase SignalingSh2 Domain-mediated SignalingSh2 DomainsSprouty-mediated Signaling RegulationTyrosine Phosphorylation Signaling
Mammalian Sprouty (Spry) proteins are now established as receptor tyrosine kinase-induced modulators of the Ras/mitogen-activated protein kinase pathway. Specifically, hSpry2 inhibits the fibroblast growth factor receptor (FGFR)-induced mitogen-activated protein kinase pathway but conversely prolongs activity of the same pathway following epidermal growth factor (EGF) stimulation, where activated EGF receptors are retained on the cell surface. In this study it is demonstrated that hSpry2 is tyrosine-phosphorylated upon stimulation by either FGFR or EGF and subsequently binds endogenous c-Cbl with high affinity. A conserved motif on hSpry2, together with phosphorylation on tyrosine 55, is required for its enhanced interaction with the SH2-like domain of c-Cbl. A hSpry2 mutant (Y55F) that did not exhibit an enhanced binding with c-Cbl failed to retain EGF receptors on the cell surface. Furthermore, individually mutating hSpry2 residues 52–59 to alanine indicated a tight correlation between their affinity for c-Cbl binding and their inhibition of ERK2 activity in the FGFR pathway. We postulate that tyrosine phosphorylation “activates” hSpry2 by enhancing its interaction with c-Cbl and that this interaction is critical for its physiological function in a signal-specific context. Mammalian Sprouty (Spry) proteins are now established as receptor tyrosine kinase-induced modulators of the Ras/mitogen-activated protein kinase pathway. Specifically, hSpry2 inhibits the fibroblast growth factor receptor (FGFR)-induced mitogen-activated protein kinase pathway but conversely prolongs activity of the same pathway following epidermal growth factor (EGF) stimulation, where activated EGF receptors are retained on the cell surface. In this study it is demonstrated that hSpry2 is tyrosine-phosphorylated upon stimulation by either FGFR or EGF and subsequently binds endogenous c-Cbl with high affinity. A conserved motif on hSpry2, together with phosphorylation on tyrosine 55, is required for its enhanced interaction with the SH2-like domain of c-Cbl. A hSpry2 mutant (Y55F) that did not exhibit an enhanced binding with c-Cbl failed to retain EGF receptors on the cell surface. Furthermore, individually mutating hSpry2 residues 52–59 to alanine indicated a tight correlation between their affinity for c-Cbl binding and their inhibition of ERK2 activity in the FGFR pathway. We postulate that tyrosine phosphorylation “activates” hSpry2 by enhancing its interaction with c-Cbl and that this interaction is critical for its physiological function in a signal-specific context. Drosophila Sprouty (dSpry) 1The abbreviations used are: dSpry, Drosophila Sprouty; RTK, receptor tyrosine kinase; MAPK, mitogen-activated protein kinase; FGF, fibroblast growth factor; FGFR, FGF receptor; EGF, epidermal growth factor; EGFR, EGF receptor; ERK, extracellular signal-regulated protein kinase; GST, glutathione S-transferase; E2, ubiquitin carrier protein; E3, ubiquitin-protein isopeptide ligase; HA, hemagglutinin. protein was first discovered in a genetic screen for novel genes implicated in tracheal branching (1Hacohen N. Kramer S. Sutherland D. Hiromi Y. Krasnow M.A. Cell. 1998; 92: 253-263Abstract Full Text Full Text PDF PubMed Scopus (644) Google Scholar), which is under the control of various growth factors including FGF. dSpry was further shown to inhibit EGFR signaling as dSpry knockout mutants displayed excess photoreceptors, cone cells, and pigment cells, whereas overexpression of dSpry mimics a loss of EGFR signaling (2Casci T. Vinos J. Freeman M. Cell. 1999; 96: 655-665Abstract Full Text Full Text PDF PubMed Scopus (394) Google Scholar). In mammals, the four Spry isoforms (Spry1–4) have been implicated as inhibitors of FGF, nerve growth factor, and vascular endothelial growth factor signaling (3Yusoff P. Lao D.H. Ong S.H. Wong E.S. Lim J. Lo T.L. Leong H.F. Fong C.W. Guy G.R. J. Biol. Chem. 2001; 277: 3195-3201Abstract Full Text Full Text PDF PubMed Scopus (180) Google Scholar, 4Lee S.H. Schloss D.J. Jarvis L. Krasnow M.A. Swain J.L. J. Biol. Chem. 2001; 276: 4128-4133Abstract Full Text Full Text PDF PubMed Scopus (123) Google Scholar, 5Impagnatiello M.A. Weitzer S. Gannon G. Compagni A. Cotton M. Christofori G. J. Cell Biol. 2001; 152: 1087-1098Crossref PubMed Scopus (239) Google Scholar). Different genetic studies have indicated that dSpry inhibits the Ras/MAPK pathway at various points including downstream of Ras activation around the level of Raf (6Reich A. Sapir A. Shilo B. Development. 1999; 126: 4139-4147Crossref PubMed Google Scholar), which coincides with studies on the point of inhibition of human Spry2 (3Yusoff P. Lao D.H. Ong S.H. Wong E.S. Lim J. Lo T.L. Leong H.F. Fong C.W. Guy G.R. J. Biol. Chem. 2001; 277: 3195-3201Abstract Full Text Full Text PDF PubMed Scopus (180) Google Scholar). Mammalian Spry2 was recently shown to prolong EGF-stimulated MAPK signaling by attenuating EGFR ubiquitination and endocytosis (7Wong E.S. Fong C.W. Lim J. Yusoff P. Low B.C. Langdon W.Y. Guy G.R. EMBO J. 2002; 21: 4796-4808Crossref PubMed Scopus (200) Google Scholar, 8Egan J.E. Hall A.B. Yatsula B.A. Bar-Sagi D. Proc. Natl. Acad. Sci. U. S. A. 2002; 99: 6041-6046Crossref PubMed Scopus (121) Google Scholar). Through its direct binding to the Ring finger domain of c-Cbl (9Wong E.S. Lim J. Low B.C. Chen Q. Guy G.R. J. Biol. Chem. 2001; 276: 5866-5875Abstract Full Text Full Text PDF PubMed Scopus (109) Google Scholar), which is an E3-ubiquitin ligase, hSpry2 appears to compete off the docking of c-Cbl onto the tyrosine-phosphorylated EGFR. Consequently, signals emanating from the EGFR are not attenuated but rather sustained. This study illustrated the dual function of Spry proteins in modulating the intensity and duration of MAPK signaling initiated by different RTKs. Two interesting observations were made during the course of our previous study: (a) upon stimulation of RTKs, the association between c-Cbl and hSpry2 was significantly increased and (b) hSpry2 was highly tyrosine-phosphorylated. The question was asked whether Spry2 and c-Cbl exhibit another level of interaction following activation of RTKs, whether this centered around tyrosine phosphorylation of Spry2, and how this may impact on the modulatory effect of Spry2 on the Ras/MAPK pathway. Antibodies, Reagents, and DNA Constructs—Monoclonal antibodies and agarose-conjugated beads against HA and FLAG epitope tags were obtained from Roche Applied Science and Sigma-Aldrich, respectively. Monoclonal anti-phospho-ERK1/2 (p44/p42) was from Cell Signaling Technology (Beverly, MA). Horseradish peroxidase-conjugated anti-phosphotyrosine (PY20), monoclonal antibodies against ERK2 and c-Cbl were purchased from Transduction Laboratories (Lexington, KY). Anti-FGFR1 was obtained from Santa Cruz Biotechnology (Santa Cruz, CA). Human c-Cbl cDNA was a kind gift from Dr. W. Langdon (University of Western Australia). The full-length c-Cbl cDNA and the various deletion mutants were constructed and subcloned into pXJ40HA vector as previously described (9Wong E.S. Lim J. Low B.C. Chen Q. Guy G.R. J. Biol. Chem. 2001; 276: 5866-5875Abstract Full Text Full Text PDF PubMed Scopus (109) Google Scholar). hSpry2 mutants were constructed using the site-directed mutagenesis kit from Clontech according to the manufacturer's instructions. The mutant products were derived using wild type FLAG-hSpry2 as template and verified by DNA sequencing. Immunoprecipitation, Western Blotting, Cell Culture, and Confocal Microscopy—Immunoprecipitation, Western blotting and cell culture were performed as described previously (3Yusoff P. Lao D.H. Ong S.H. Wong E.S. Lim J. Lo T.L. Leong H.F. Fong C.W. Guy G.R. J. Biol. Chem. 2001; 277: 3195-3201Abstract Full Text Full Text PDF PubMed Scopus (180) Google Scholar). M2 (anti-FLAG-conjugated agarose) beads were used for immunoprecipitating FLAG-tagged proteins, whereas anti-HA-conjugated agarose beads were used for HA-tagged proteins. Confocal microscopy was carried out by seeding COS-7 cells onto 60-mm diameter tissue culture dishes in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum. At 70% confluency, the cells were transfected with 1–2 μg of FLAG-tagged plasmid DNA using FuGENE 6 reagent (Roche Applied Science) according to the manufacturer's instructions. On the following day, the cells were trypsinized and plated into 6-well plates containing sterilized glass coverslips at a confluency of 30%. The cells were treated with or without EGF (50 ng/ml) for 30 min before fixing in 3% paraformaldehyde in PBSCM (phosphate-buffered saline containing 10 mm CaCl2 and 10 mm MgCl2) buffer for 30 min at room temperature, then permeabilized with 0.1% saponin (Sigma-Aldrich) in PBSCM for 15 min at room temperature. Anti-FLAG monoclonal antibody (Sigma-Aldrich) was used at 1 μg/100 μl in fluorescence dilution buffer (3% bovine serum albumin in PBSCM). After washing three times with PBSCM buffer, Texas Red dye-conjugated AffiniPure goat anti-mouse IgG (Jackson ImmunoResearch Laboratories Inc., West Groove, PA) was added to the cells at 1 μg/100 μl. The coverslips were mounted using Gel-Mount and viewed with an MRC-1024 (Bio-Rad) laser scanning confocal microscope. Far Western Assay—FLAG-tagged were transfected into cells using FuGENE 6 the cells were and the FLAG-tagged proteins were with M2 by and onto The was then with 3% in (phosphate-buffered saline containing 0.1% and then with 1 protein in 3% in and 1 mm for protein was off with and with monoclonal antibody (Santa Cruz by anti-mouse peroxidase-conjugated antibody receptor was performed as previously described (7Wong E.S. Fong C.W. Lim J. Yusoff P. Low B.C. Langdon W.Y. Guy G.R. EMBO J. 2002; 21: 4796-4808Crossref PubMed Scopus (200) Google Spry2 upon in an with indicated that hSpry2 was tyrosine-phosphorylated upon stimulation by various growth on the tyrosine residues with were and the following was The effect of EGF stimulation on hSpry2 point was by FLAG-tagged hSpry2 in COS-7 cells high of endogenous EGF receptors are by stimulation with EGF (50 ng/ml) for 10 min and the M2 Spry2 protein with anti-phosphotyrosine that with wild type hSpry2, mutating tyrosine to the phosphorylation upon EGF stimulation of the tyrosine residues were but of are Furthermore, the mutant failed to with a protein that was previously as c-Cbl (9Wong E.S. Lim J. Low B.C. Chen Q. Guy G.R. J. Biol. Chem. 2001; 276: 5866-5875Abstract Full Text Full Text PDF PubMed Scopus (109) Google Scholar). The wild type hSpry2 and mutants did not level of tyrosine phosphorylation as indicated by the of signals in the The of FGFR activation on the hSpry2 tyrosine point in cells were the overexpression of which is and mimics the FGF signaling in to EGF stimulation, hSpry2 to as are the point mutants with the of c-Cbl was demonstrated to with hSpry2, as were the various tyrosine to with the of for tyrosine in a of at the whether the rather was to for the loss of binding to further to various alanine and hSpry2 mutants were for binding to and failed to not that the tyrosine is for c-Cbl mutants failed to tyrosine-phosphorylated with EGF or with We asked whether the tyrosine interaction in direct binding between c-Cbl and this a Western a protein was and used to a of hSpry2 and proteins in cells The was to protein and subsequently with to the of hSpry2 was in the of hSpry2 and cells whereas a was in the from cells first This that c-Cbl protein binds to hSpry2, and with a significantly affinity for the tyrosine-phosphorylated The mutant interaction with with a level of binding in the of The from cells did not and that the binding of c-Cbl to hSpry2 and is We previously the binding of hSpry2 and c-Cbl (9Wong E.S. Lim J. Low B.C. Chen Q. Guy G.R. J. Biol. Chem. 2001; 276: 5866-5875Abstract Full Text Full Text PDF PubMed Scopus (109) Google Scholar). studies that to an enhanced interaction between proteins following We were in the of binding between c-Cbl and hSpry2 and of and to the physiological of this dual of We that the interaction between c-Cbl and tyrosine-phosphorylated hSpry2 was significantly their protein was used in binding to of to the between c-Cbl and hSpry2 may not the are in a on Spry2 for c-Cbl of the of Spry2 residues 52–59 the Spry isoforms an alanine of residues was performed to their effect on c-Cbl In the alanine mutants did not level of tyrosine and c-Cbl was not in the under the We then the of mutants to with endogenous c-Cbl upon of mutating residues and to alanine in a loss of c-Cbl to the mutant and hSpry2 mutants were and with to are conserved Spry The that hSpry2 which on tyrosine 55, its binding with c-Cbl the residues at the and to the tyrosine are The SH2-like of c-Cbl to a the that been to to a tyrosine-phosphorylated We performed an to this interaction of c-Cbl that were used previously to the interaction with hSpry2 (9Wong E.S. Lim J. Low B.C. Chen Q. Guy G.R. J. Biol. Chem. 2001; 276: 5866-5875Abstract Full Text Full Text PDF PubMed Scopus (109) Google Scholar). the c-Cbl with either or that were for interaction was with the various c-Cbl deletion mutants in the or of FLAG-hSpry2 in M2 beads were used for by and Western The control that the c-Cbl not with the M2 In the of c-Cbl or were but not the SH2-like domain or FLAG-hSpry2 protein in the was by overexpression and the binding of and that the SH2-like domain of c-Cbl is for binding to tyrosine-phosphorylated is a of binding between c-Cbl and hSpry2 in the and The c-Cbl containing the Ring finger motif were previously shown to (9Wong E.S. Lim J. Low B.C. Chen Q. Guy G.R. J. Biol. Chem. 2001; 276: 5866-5875Abstract Full Text Full Text PDF PubMed Scopus (109) Google Scholar). further the of this interaction in the shown in without A of c-Cbl to in were with the of the c-Cbl not have the Ring finger motif on the shown in as an control for The in that c-Cbl the Ring finger motif and with A of cell was in this which the that the interaction between c-Cbl and hSpry2 is with the to EGFR at the Cell previously shown that hSpry2, an interaction with the of which subsequently to a activation of the MAPK pathway (7Wong E.S. Fong C.W. Lim J. Yusoff P. Low B.C. Langdon W.Y. Guy G.R. EMBO J. 2002; 21: 4796-4808Crossref PubMed Scopus (200) Google Scholar). c-Cbl been shown to on EGFR G. M. S. Y. A. S. Y. Cell. 1999; Full Text Full Text PDF PubMed Scopus Google Scholar), which is a that to the conserved Spry motif shown in A for the inhibition of EGFR endocytosis is that hSpry2 an binding for the SH2-like domain of which compete for the binding of c-Cbl to tyrosine-phosphorylated and subsequently inhibit receptor In it the phosphorylation motif interaction that the endocytosis rather the and interaction between hSpry2 and the c-Cbl Ring finger In this modified to inhibit EGFR this the of wild type hSpry2 and on the of EGFR COS-7 cells were in this of the high level of endogenous EGFR. in whereas COS-7 cells enhanced the of of activated EGFR, cells transfected with c-Cbl and hSpry2 an with the of hSpry2 (7Wong E.S. Fong C.W. Lim J. Yusoff P. Low B.C. Langdon W.Y. Guy G.R. EMBO J. 2002; 21: 4796-4808Crossref PubMed Scopus (200) Google Scholar, 8Egan J.E. Hall A.B. Yatsula B.A. Bar-Sagi D. Proc. Natl. Acad. Sci. U. S. A. 2002; 99: 6041-6046Crossref PubMed Scopus (121) Google Scholar). failed to receptor and the EGFR were to at The level of the various is shown in A of c-Cbl in signaling is to function as an E3-ubiquitin ligase, on as the EGFR G. M. S. Y. A. S. Y. Cell. 1999; Full Text Full Text PDF PubMed Scopus Google Scholar). We previously shown that hSpry2 with c-Cbl ubiquitination of EGFR of the for the Ring finger domain of c-Cbl with the ligase, (7Wong E.S. Fong C.W. Lim J. Yusoff P. Low B.C. Langdon W.Y. Guy G.R. EMBO J. 2002; 21: 4796-4808Crossref PubMed Scopus (200) Google Scholar). our that protein not exhibit an enhanced interaction with c-Cbl upon stimulation, this is to whether the or tyrosine binding with c-Cbl is to EGFR together with hSpry2, and were transfected into cells, and the were Western and for the of proteins in EGFR as previously described (7Wong E.S. Fong C.W. Lim J. Yusoff P. Low B.C. Langdon W.Y. Guy G.R. EMBO J. 2002; 21: 4796-4808Crossref PubMed Scopus (200) Google Scholar). type hSpry2 was to significantly the of ubiquitin onto EGFR, whereas the mutant a ubiquitination of EGFR This that tyrosine phosphorylation of hSpry2 is a in the of the ubiquitination of EGFR and the in the endocytosis of activated The inhibition of EGFR ubiquitination by the mutant may to the previously interaction the of Spry2 with the Ring finger domain of c-Cbl (9Wong E.S. Lim J. Low B.C. Chen Q. Guy G.R. J. Biol. Chem. 2001; 276: 5866-5875Abstract Full Text Full Text PDF PubMed Scopus (109) Google Scholar). The of Spry proteins a domain that is for their into upon stimulation J. Wong E.S. Ong S.H. Yusoff P. Low B.C. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). The of Spry2 to into the cell is to in a loss of Spry2 including inhibition of cell and Y. L. S. J. Biol. Chem. 2001; 276: Full Text Full Text PDF PubMed Scopus Google Scholar). is of a in was to which its to function its wild type We by confocal the of to into In COS-7 cells, that wild type hSpry2 and that to a as described previously J. Wong E.S. Ong S.H. Yusoff P. Low B.C. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). The of EGF (50 ng/ml) for 10 min the of hSpry2 and to the cell is that its to retain EGFR on the cell of We previously established a for Spry isoforms that an Spry domain was for function J. Wong E.S. Ong S.H. Yusoff P. Low B.C. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). the point of not impact on this it that the phosphorylation of hSpry2 on the and the of the and that are for hSpry2 interaction with c-Cbl in the of EGFR This further that the highly conserved domain as as the highly conserved three residues centered on are for Spry hSpry2 the of FGFR or hSpry2 appears to a ubiquitination from the were to whether is of ubiquitination in the FGFR c-Cbl was shown to FGFR signaling by ubiquitination of FGFR and its protein A. B. A. J. Proc. Natl. Acad. Sci. U. S. A. 2002; 99: PubMed Scopus Google Scholar). are of the FGFR signaling of their activity or of their to have a effect on the of the We a to that described for ubiquitination of EGFR and the of a are shown in The of ubiquitin onto was not by hSpry2 but was by the In the of the level of ubiquitination was not with of of c-Cbl did not in enhanced that the for may not c-Cbl. This for the of hSpry2, which binds to c-Cbl upon to and ubiquitination as it for EGFR. This was to in a previous study A. B. A. J. Proc. Natl. Acad. Sci. U. S. A. 2002; 99: PubMed Scopus Google Scholar). of MAPK by hSpry2 on with Spry EGF by binding and ubiquitination it appears that the interaction in the of the FGFR pathway may around the of c-Cbl to as a docking protein for proteins and the of protein following hSpry2 tyrosine We whether tyrosine phosphorylation of hSpry2 or the binding of c-Cbl was to the of hSpry2 to inhibit the Ras/MAPK pathway. this question the various alanine mutants in the of this study: which not c-Cbl and and of which are tyrosine-phosphorylated but not c-Cbl. The of by the alanine mutants was by and Western with a antibody that the phosphorylation of on and tyrosine residues was then into cells to hSpry2 mutants that failed to c-Cbl in a displayed a loss of function and appears that the inhibition of the MAPK pathway by hSpry2 binding to c-Cbl and not on tyrosine phosphorylation of hSpry2 ubiquitination demonstrated that the point mutant was transfected into cells, hSpry2 was to the MAPK pathway not This that the the activated of not the ubiquitin activity of this protein to its physiological from that are to and have indicated that Spry proteins inhibit the Ras/MAPK pathway. studies in and cell that of the four Spry2 is in this pathway. inhibits the Ras/MAPK to the dSpry that with hSpry2 the Ras/MAPK by attenuating receptor endocytosis (7Wong E.S. Fong C.W. Lim J. Yusoff P. Low B.C. Langdon W.Y. Guy G.R. EMBO J. 2002; 21: 4796-4808Crossref PubMed Scopus (200) Google Scholar, 8Egan J.E. Hall A.B. Yatsula B.A. Bar-Sagi D. Proc. Natl. Acad. Sci. U. S. A. 2002; 99: 6041-6046Crossref PubMed Scopus (121) Google Scholar). The of our (a) to tyrosine phosphorylation of Spry proteins, (b) to that to hSpry2 and in the of the Ras/MAPK in the of signaling or EGFR and to that In this established that of is tyrosine-phosphorylated following activation of and and that this and residues and on a are to with a protein to the modulatory of hSpry2 on the Ras/MAPK pathway. on previous observations to the increased interaction of c-Cbl and following FGFR stimulation, asked whether c-Cbl is a for the The that c-Cbl may a in hSpry2 inhibition of the Ras/MAPK pathway as as the of EGFR of the protein are to the is that point at and on the hSpry2 protein individually binding to and with an to inhibit the Ras/MAPK pathway. A. T. T. A. J. Biol. Chem. 2001; 276: Full Text Full Text PDF PubMed Scopus Google have shown to a mutant that failed to inhibit a as to function as a the that may on the of for hSpry2 in to (a) the of on the cell and (b) the inhibition of the Ras/MAPK A of the of the EGFR in to the MAPK pathway described as of EGF receptor which subsequently of various tyrosine residues on the domain of EGFR. Two of are described for is a for the domain of and in the of MAPK D. J. Cell Biol. PubMed Google Scholar). At the same another is a binding motif for the domain of c-Cbl G. M. S. Y. A. S. Y. Cell. 1999; Full Text Full Text PDF PubMed Scopus Google Scholar). The association with c-Cbl for of the EGFR with which further the pathway the for protein G. M. S. Y. A. S. Y. Cell. 1999; Full Text Full Text PDF PubMed Scopus Google Scholar). The Ring finger domain of c-Cbl in this its as an E3-ubiquitin ligase, ubiquitin from an which been as in the EGFR context. is a between activation and the of phosphorylation and ubiquitination on the EGFR. been shown that the hSpry2 is as a of MAPK stimulation S. N. M. 2001; PubMed Scopus Google Scholar). In the activated hSpry2 in the J. Yusoff P. Wong S. Lao Fong C.W. Guy G.R. Cell Biol. 2002; PubMed Scopus Google Scholar). hSpry2 and EGFR been shown to in J. Wong E.S. Ong S.H. Yusoff P. Low B.C. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). hSpry2 in this either or by the RTK, and the an for the domain of c-Cbl to is that hSpry2 the ubiquitin from the EGFR, which is subsequently retained on the of the cells, with the Ras/MAPK pathway in the (7Wong E.S. Fong C.W. Lim J. Yusoff P. Low B.C. Langdon W.Y. Guy G.R. EMBO J. 2002; 21: 4796-4808Crossref PubMed Scopus (200) Google Scholar, 8Egan J.E. Hall A.B. Yatsula B.A. Bar-Sagi D. Proc. Natl. Acad. Sci. U. S. A. 2002; 99: 6041-6046Crossref PubMed Scopus (121) Google Scholar). hSpry2 is a of c-Cbl The binding between hSpry2 and c-Cbl may a in the in to to are a of in the where affinity binding a and high affinity The for the interaction of hSpry2 with the FGFR is but from the EGFR The of the activation of the Ras/MAPK pathway from a of from the T. J. Bar-Sagi D. J. Cell. Full Text Full Text PDF PubMed Scopus Google Scholar, J. Cell Biol. 2001; Scopus Google Scholar). are four on a binding motif T. J. Bar-Sagi D. J. Cell. Full Text Full Text PDF PubMed Scopus Google and downstream a binding for the domain of the tyrosine J. Cell Biol. 2001; Scopus Google Scholar). to the of the MAPK activation pathway from the which then binds and subsequently downstream to of the EGFR pathway. is that where the domain of binds to the domain binds to c-Cbl a binding interaction A. B. A. J. Proc. Natl. Acad. Sci. U. S. A. 2002; 99: PubMed Scopus Google Scholar). c-Cbl with for the domain of and signaling to the Ras/MAPK pathway. This another of the of and signals on the same signaling hSpry2 appears on the in the FGFR is The into a receptor to that with the EGFR hSpry2 binds to c-Cbl and then may inhibit the activation of the Ras/MAPK pathway of a of (a) by c-Cbl from may of the signaling to or (b) as a protein Langdon W.Y. Cell Biol. 2001; PubMed Scopus Google Scholar), may a of the MAPK pathway or a into a to its The in this that ubiquitination is to a in the FGFR signaling by the of hSpry2, FGFR, and hSpry2 are it appears that the interaction of and c-Cbl is to and of the from various from Drosophila to that are The first is the Spry domain that the of the domain and a that been shown to for binding the J. Yusoff P. Wong S. Lao Fong C.W. Guy G.R. Cell Biol. 2002; PubMed Scopus Google Scholar). The is the motif a that is for Spry2 the protein with this is c-Cbl. signaling proteins have been implicated as in the function of Spry isoforms D. M. S. S. D. J. 2002; PubMed Scopus Google Scholar, Y. N. A. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). A direct effect on for a with to FGFR signaling it is in and the of downstream is not in and a of hSpry2 function the may as at the of Spry this was under S. T. Cell. Biol. 2002; PubMed Scopus Google the phosphorylation of Spry2 on the same tyrosine as described in this At the same Y. S. Y. Biol. Full Text Full Text PDF PubMed Scopus Google and Hall A.B. N. J. D. Bar-Sagi D. Biol. Full Text Full Text PDF PubMed Scopus Google that Spry2 is a for ubiquitination and We Low and for Lo and Lao for and for critical of the
23
Sprouty, an Intracellular Inhibitor of Ras Signaling
Tanita Casci, Javier Vinós, Matthew Freeman · Cell · 1999 · 464 citations · Full text